Patents by Inventor Tiziana Crepaldi

Tiziana Crepaldi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-MET FAB-FC FOR THE TREATMENT OF A TUMOR AND/OR METASTASIS
    Publication number: 20210395372
    Abstract: An anti-Met antibody fragment comprising a single antigen binding arm and an Fc region, wherein the antigen binding arm is defined by the variable regions having amino acid sequences as set forth in SEQ ID No.: 7, 8 and wherein the anti-Met antibody fragment is useful in the treatment of a tumor and/or metastasis.
    Type: Application
    Filed: October 7, 2019
    Publication date: December 23, 2021
    Inventors: Elisa VIGNA, Cristina BASILICO, Tiziana CREPALDI, Paolo Maria COMOGLIO
  • Pharmaceutical composition containing ezrin mutated on tyrosin 353
    Publication number: 20020115633
    Abstract: The invention relates to a pharmaceutical composition containing an effective amount of ezrin mutated on tyrosine 353, or a functional fragment or derivative thereof, in association with a pharmaceutically acceptable carrier, for use preferably in the prevention and/or treatment of tumors.
    Type: Application
    Filed: April 8, 2002
    Publication date: August 22, 2002
    Applicant: Institute Curie
    Inventors: Monique Arpin, Tiziana Crepaldi, Alexis Gautreau, Daniel Louvard
  • Pharmaceutical composition containing ezrin mutated on tyrosine 353
    Patent number: 6399584
    Abstract: The invention relates to a pharmaceutical composition containing an effective amount of ezrin mutated on tyrosine 353, or a functional fragment or derivative thereof, in association with a pharmaceutically acceptable carrier, for use preferably in the prevention and/or treatment of tumors.
    Type: Grant
    Filed: March 18, 1998
    Date of Patent: June 4, 2002
    Assignees: Institute Curie, Centre National de Recherche Scientfique
    Inventors: Monique Arpin, Tiziana Crepaldi, Alexis Gautreau, Daniel Louvard
  • Truncated forms of the hepatocyte growth factor (HGF) receptor
    Patent number: 5571509
    Abstract: A protein, which is useful as an antagonist of hepatocyte growth factor, is composed of two disulphide-linked chains of 50 kDa and 75 or 85 kDa respectively, the 5 kDa chain being the .alpha.-chain of the tyrosine kinase encoded by the MET protooncogene and the 75 or 85 kDa chain being a C-terminal truncated form of the .beta.-chain of the said tyrosine kinase.
    Type: Grant
    Filed: May 7, 1992
    Date of Patent: November 5, 1996
    Assignee: Farmitalia Carlo Erba S.R.L.
    Inventors: Paolo Comoglio, Tiziana Crepaldi, Maria Prat